About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: May 7, 2008
FDA Issues Another Approvable Letter
This time, the letter was directed to Astellas, and it isn’t the first one. According to an Astellas press release that was issued today, the company stated that it received an approvable letter for its NDA for FK 506 Modified … Continue reading
Posted in Approvable Letters
Comments Off on FDA Issues Another Approvable Letter